CEO
Raffaele Ingenito PhD , entrepreneurial mindset with a strong foundation in pharmaceutical management and scientific research, cofounded Enhydro Science in 2023 and at since January 2026 is the CEO .
Results-driven Scientific and Strategic Leader with 25+ years in pharmaceutical R&D, project coordination, and clinical operations. Strong record of aligning scientific innovation with business goals in biotech and pharma environments.
Extensive experience in pharmaceuticals and strategic planning including protein/ peptide-based therapeutics, with clinical trial oversight, IP strategy, product launches.
Entrepreneurial mindset with a strong foundation in pharmaceutical management and scientific research.
Marco Mattu, PhD, MD is Cofounder and Scientific Board member – Medical Doctor and PhD in Clinical Biochemistry at the University of Rome has more than 15 years of pharmaceutical R&D experience. He is expert of Clinical and Functional Nutrition.
Francesca Varrone, PhD, is Cofounder and Molecular and Cellular Biologist with a PhD in Genetics and Molecular Medicine with 15 years of strong scientific expertise in leading numerous drug discovery and translational research programs in Biotech / Pharma R&D. More than 10 years of experience leading multiple scientific teams in small-molecule drug discovery programs associated with oncology, regenerative medicine, and muscle-related disease, including developing and managing budgets and other financial aspects and business operations.
Enhydro Science has established a number of research projects and collaborative partnerships with research groups from various universities, including the Department of Biology and the Department of Agricultural Genetics at the University of Naples Federico II, and the Department of Pharmacy, Health and Nutritional Sciences at the University of Calabria.